Summary:
If you are living with Major Depressive Disorder (MDD), you already know that it is more than just a sad feeling. MDD is a disorder that can cause symptoms such as a continuous low mood, feelings of hopelessness, and a lack of interest or pleasure in activities that are usually enjoyed. Although there are treatment options available, these treatments are not effective for all patients and often have side effects that can cause people to stop taking them. Many current MDD medications do not adequately address lost interest in previously pleasurable activities.
What is the purpose of this research study?
The main purpose of this study is to evaluate the safety and effectiveness of the investigational drug in people who have Major Depressive Disorder (MDD). This study will also assess the effect that the investigational drug has on the ability to feel pleasure or happiness in people with MDD.
Qualified Participants Must:
• Ages 25 to 65 with MDD
•
Have a reduced ability to experience happiness or pleasure
•
Have been in a depressive episode at least 2 weeks but not more than 6 months
•
The complete list of requirements to participate in this study will be discussed with you by the study staff
•
People who are interested in participating must first be qualified. The qualification process, called screening, involves a medical history, an examination, and a series of tests
•
Study candidates must meet all entry criteria to participate in the treatment portion of this study. Not all those who screen for this study will be eligible to participate.
Qualified Participants May Receive:
May receive compensation for time and travel.